$29.770
+2.179 (+7.32%)終値時点
PHVS の収益性とマージン
Evaluating the bottom line, Pharvaris N.V. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -70.46%, provide a clear picture of how effectively PHVS converts its operational activities into shareholder value.
PHVS の同業比較
In the context of the broader market, PHVS competes directly with industry leaders such as IMNM and ALVO. With a market capitalization of $2.18B, it holds a significant position in the sector. When comparing efficiency, PHVS's gross margin of N/A stands against IMNM's N/A and ALVO's 50.71%. Such benchmarking helps identify whether Pharvaris N.V. is trading at a premium or discount relative to its financial performance.
Pharvaris NV の財務パフォーマンス
Pharvaris has reported consistent net losses, with the latest loss at €47.8 million for Q2 2026, and a negative EPS of -0.70. Despite this, the company has a strong current ratio of 11.94, indicating good liquidity.
Financials
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。